RN Mobile Menu


Rheumatology Network

Beyond Zika: 7 Things Rheumatologists Should Know about Chikungunya

Cleveland Clinic's Leonard Calabrese, D.O., talks with Rheumatology Network about chikungunya, a mosquito-borne viral disease that mimics arthritis. (nechaevkon/Shutterstock.com)

Recent Content


Research points to evidence showing that microorganisms inside our bodies could play a role in the development of arthritis, but it could also be a new therapeutic pathway.

Leonard Calabrese, D.O.

With the spread of Zika virus rating as a "public health emergency" by the World Health Organization, another emerging mosquito-borne illness is worrying rheumatologists: chikungunya.

Eric Morand, M.D., PhD.

Eric Morand, M.D., Ph.D., Director of Rheumatology at Monash Health in Australia, speaks with Rheumatology Network about his recent article in Nature Reviews Rheumatology.


Study shows that 14-3-3η protein serum levels can more accurately identify patients with early polyarthritis at risk for long-term poor outcomes.

In 2015, ACR and EULAR issued classification criteria for gout. The scoring system is summarized here in an easy to use format for physicians and patients.


Few gout patients know their serum urate goals, which researchers say could hinder their chances of reaching remission.

Seth Lederman M.D.

Profiles in Rheumatology: Seth Lederman, M.D., chairman and CEO of Tonix Pharmaceuticals

By clicking Accept, you agree to become a member of the UBM Medica Community.